Atlanta Medical Center, Inc.

Atlanta, Georgia 30312

0 studies enrolling now · 2 studies all time

What they study most

Hepatitis C, Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders — Stopped early